Document is current
Any future updates will be listed below
-
Authors
Aiello, Edoardo Nicolò
Curti, Beatrice
Torre, Silvia
De Luca, Giulia
Maranzano, Alessio
Colombo, Eleonora
Gendarini, Claudia
Cocuzza, Alessandro
Messina, Stefano
Doretti, Alberto
Verde, Federico
Morelli, Claudia
Silani, Vincenzo
Ticozzi, Nicola
Poletti, Barbara https://orcid.org/0000-0003-4398-2051
-
Funding
Funding for this research was provided by:
Ministero della Salute (NA)
- License Information
-
More Information
Article History
Received: 13 June 2024
Accepted: 29 September 2024
First Online: 15 October 2024
Declarations
:
: Participants provided informed consent and data were treated according to current regulations. This study was approved by the Ethics Committee of IRCCS Istituto Auxologico Italiano (ID: 2013_06_25).
: V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG, Amylyx Pharmaceuticals, Biogen, and Zambon Biotech SA, receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, Frontiers in Neurology. B.P. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. B.P. is Associate Editor for Frontier in Neuroscience. N. T. received compensation for consulting services from Amylyx Pharmaceuticals, Biogen, Italfarmaco and Zambon Biotech SA. He is Associate Editor for Frontiers in Aging Neuroscience. E.N.A. serves as an Editorial Board Member for BMC Neurology. F.V. is Associate Editor for Journal of Alzheimer’s Disease. A.D. received compensation for consulting services and/or speaking activities from ABBVIE, Eli Lilly, Teva, Lundbeck, Novartis, Zambon, Neopharmed Gentili, Piam.
